DLPIC
XENT

Davide Leone & Partners Investment Company’s Intersect ENT, Inc XENT Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-109,240
Closed -$2.28M – 121
2021
Q1 		$2.28M Buy
109,240
+32,949
+43% +$760K 0.28% 40
2020
Q4 		$1.75M Buy
+76,291
New +$1.45M 0.18% 45

Other funds holding XENT

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Davide Leone & Partners Investment Company's XENT Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of Intersect ENT, Inc (XENT) in Q2 2021, closing a stake of 109,240 shares — an estimated $2.28M sold.

Davide Leone & Partners Investment Company first reported a position in XENT in Q4 2020 and held it in 2 quarters. The position peaked at $2.28M in Q1 2021. 107 funds tracked by Wall St. Rank hold XENT as of Q2 2021.

  • Davide Leone & Partners Investment Company reported no remaining Intersect ENT, Inc position as of Q2 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 109,240 Intersect ENT, Inc shares in Q2 2021, an estimated $2.28M.
  • Davide Leone & Partners Investment Company first reported a position in Intersect ENT, Inc in Q4 2020 and held it in 2 quarters.
  • Davide Leone & Partners Investment Company's Intersect ENT, Inc position peaked at $2.28M in Q1 2021.
  • 107 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.